Walleye Capital’s Intelligent Medicine Acquisition Corp. Class A Common Stock IQMD Stock Holding History

Walleye Capital’s Portfolio IQMD Stock Details IQMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-111,873	Closed	-$1.15M	–	5169
2023 Q1	$1.15M	Buy	111,873 +8,724	+8%	+$89.6K	0.02%	1062
2022 Q4	$1.06M	Hold	103,149	–	–	0.02%	965
2022 Q3	$1.04M	Hold	103,149	–	–	0.02%	945
2022 Q2	$1.03M	Sell	103,149 -9,820	-9%	-$98.2K	0.03%	631
2022 Q1	$1.13M	Buy	+112,969	New	+$1.12M	0.03%	582

Walleye Capital's IQMD Position: Q2 2023 in Review

Walleye Capital sold out of Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) in Q2 2023, closing a stake of 111,873 shares — an estimated $1.15M sold.

Walleye Capital first reported a position in IQMD in Q1 2022 and held it in 5 quarters. The position peaked at $1.15M in Q1 2023. 0 funds tracked by Wall St. Rank hold IQMD as of Q2 2023.

Walleye Capital reported no remaining Intelligent Medicine Acquisition Corp. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Walleye Capital sold 111,873 Intelligent Medicine Acquisition Corp. Class A Common Stock shares in Q2 2023, an estimated $1.15M.
Walleye Capital first reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock in Q1 2022 and held it in 5 quarters.
Walleye Capital's Intelligent Medicine Acquisition Corp. Class A Common Stock position peaked at $1.15M in Q1 2023.
0 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Class A Common Stock as of Q2 2023.

Based on Walleye Capital's 13F filing for Q2 2023, filed 14 Aug 2023.